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Alveolar macrophages (AM) originate from blood monocytes and, during the maturation process, undergo 
functional and morphological changes which are also reflected in their phenotypic pattern. Among the macrophage 
membrane antigens, adhesion molecules of the integrin family are particularly important for effector functions and 
cell-cell interactions. The aim of this study was to analyse the membrane expression of selected integrins by AM 
recovered from bronchoalveolar lavage (BAL) as compared to their precursors, peripheral blood monocytes (PBM). 
The cells were stained using a sensitive immunoperoxidase assay with 10 different monoclonal antibodies. The data 
showed a higher expression by AM than PBM of all but one of the studied adhesion molecules. The only exception 
was CD1 lb (Mac-l, CR3) which showed a higher expression in PBM than in AM. Several molecules, for example, 
CD49d (VLA-4), CD51 (vitronectin receptor), and CD54 (intercellular adhesion molecule-l, ICAM-1) were found 
to be upregulated by AM in patients with a lymphocytic pattern of BAL. In contrast, the phenotype of PBM does 
not show any changes in these patients. In conclusion, we have demonstrated differences in the expression of 
integrins between AM and PBM which can be partially responsible for some of their functional differences. 
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Introduction 
Alveolar macrophages (AM), originating from peripheral 
blood monocytes (PBM), play a major role in immune and 
inflammatory reactions as well as in the repair of lung 
tissue. The phenotypic pattern of AM and PBM reflects 
both the process of maturation/differentiation and the effect 
of microenvironmental stimuli. 
Adhesion molecules of the integrin family and their 
ligands are of particular importance for traffic, effector 
functions, and regulatory cell-cell interactions of mononu- 
clear phagocytes (1). Previous studies showed increased 
expression of several of these molecules by alveolar macro- 
phages from patients with sarcoidosis (2,3), idiopathic 
pulmonary fibrosis (4) extrinsic allergic alveolitis (5), and 
lung cancer (6). This alteration in the expression of integrins 
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by the AM population may be explained either by an 
increased influx of PBM to the lung (7), or by an enhanced 
activation of resting macrophages (8). 
The purpose of our study was to compare simultaneously 
the expression of integrins on AM and blood monocytes 
obtained from subjects with different degrees of alveolar 
infiltration by immune and inflammatory cells. Molecules 
of the pi, /& and pa integrins were analysed on the mem- 
brane of blood and lung mononuclear phagocytes using 
a sensitive immunoperoxidase assay with monoclonal 
antibodies. 
Methods 
STUDY POPULATION 
Thirty-five subjects were included in the study (mean age 41 
years, range 19-58 years, 24 men and 11 women, nine were 
smokers). In 11 subjects, bronchoalveolar lavage (BAL) 
cytology showed a normal differential cell count (percent- 
age of AM>85%), this group consisted of individuals 
undergoing routine bronchoscopy for differential diagnos- 
tic purposes without final evidence of lung disease. In all of 
them, the lung lavaged was radiographically normal. A 
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TABLE 1. Monoclonal antibodies used in the study 
CD Antigen Antibody Source 
CD49b 
CD49d 
CD49e 
CD49f 
CD1 la 
CDllb 
CDllc 
CD18 
CD51 
CD54 
VLA-2 alpha chain, collagen receptor 
VLA-4 alpha chain, fibronectin and VCAM-1 receptor 
VLA-5 alpha chain, fibronectin receptor 
VLA-6 alpha chain, laminin receptor 
LFA-1 alpha chain 
CR3, Mac-l alpha chain 
CR4, p150/95 alpha chain 
beta chain of p2 integrins 
alpha v chain of p3 integrins, vitronectin receptor 
ICAM- (ligand for p2 integrins) 
IOP49b 
IOP49d 
IOP49e 
IOP49f 
IOT16 
OKMl 
KiMl 
IOT18 
IOP51 
IOL54 
Dianova 
Dianova 
Dianova 
Dianova 
Dianova 
Ortho Diagn. 
Behring 
Dianova 
Dianova 
Dianova 
selective increase in the percentage of BAL lymphocytes 
(>15%) was found in 14 subjects including eight patients 
with active pulmonary sarcoidosis, four patients with 
extrinsic allergic alveolitis, and two patients with tubercu- 
losis. A selective increase in the percentage of BAL neu- 
trophils (>5%) was found in 10 patients with idiopathic 
pulmonary fibrosis. Patients with an increased percentage 
of both lymphocytes and neutrophils were excluded from 
this study. 
Informed consent was obtained according to institutional 
guidelines. 
BRONCHOALVEOLAR LAVAGE 
After local anaesthesia (10% lidocaine solution) a fibre- 
optic bronchoscope was passed transorally and wedged in a 
segmental or subsegmental bronchus of the right middle 
lobe, BAL was performed by the instillation of 5 x 20 ml of 
saline (0.9% NaCl), and the fluid was aspirated immediately 
after each aliquot. The lavaged cells were passed through 
gauze and collected by centrifugation at 500 g for 10 min at 
4°C. The total cell count was determined in a haemocytom- 
eter, and the differential count of BAL cells was evaluated 
on slides stained by May-Giemsa-Gruenwald. The viability 
of cells was assessed by Trypan blue exclusion. 
DETERMINATION OF MONONUCLEAR 
PHAGOCYTE PHENOTYPE , 
The expression of membrane antigens on AM and density 
separated blood monocytes was studied by the immunoper- 
oxidase slide assay as described previously in detail (9) with 
minor modifications. Ten ,~l of cell suspension (2 x lo6 cells 
ml-‘) were transferred to reaction areas of adhesive slides 
(Bio-Rad, Munich, Germany). After attachment, the cells 
were fixed with 0.05% glutaraldehyde, followed by washing 
with NKH medium and preincubation with a gelatine- 
containing medium to prevent immunoglobulin binding to 
the glass surface. The staining procedure included the 
following steps: 5min incubation with monoclonal anti- 
body (see Table 1); 5,min incubation with rabbit anti-mouse 
immunoglobulins (Dako); 5 min incubation with swine 
anti-rabbit immunoglobulins (Dako); 5 min incubation 
with peroxidaseeantiperoxidase complex from rabbit 
(Dako); 10 min incubation with diaminobenzidine (Sigma) 
followed by postfixation with 0~0, (Sigma). To evaluate 
the reaction, the slides were viewed under a light micro- 
scope, a positive reaction was denoted by the presence of 
dark brown, granular staining of the cell membrane. The 
slight endogeneous intracellular activity did not interfere 
with the membrane staining of the cell surface and was 
useful in order to distinguish monocytes and macrophages 
from large lymphocytes. 
STATISTICS 
All data are expressed as mean&SD. The Student’s t-test 
or the Kruskal-Wallis test (non-parametric distribution 
of data) were used for comparisons between groups, 
Spearman’s rank correlations were used to evaluate the 
correlation between the expression of antigens on PBM and 
AM. P values below 0:0’5 were considered significant. 
pits h r: 
The comparison of integrin expression between AM and 
PBM showed almost identical trends in all three groups of 
patients (Table 2). This allowed us to evaluate the differ- 
ences in the expression of integrins between AM and PBM 
in the total population of consecutive subjects. The mean 
differences in the membrane expression of the studied 
antigens between AM and blood PBM are shown in Fig. 1 
and demonstrate preferential expression of all but one 
(CDllb) adhesion molecules by AM. Membrane expres- 
sion of CD54 and CD51 showed the most striking 
difference between AM and PBM. 
MOLECULES OF THE ,f?, INTEGRIN FAMILY 
The CD49b antigen was expressed on a limited percentage 
of AM (5 + 9%, range 048%) and absent on PBM (cl%) 
in all study subjects (P<O.OOl). 
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TABLE 2. Expression of adhesion molecules on peripheral blood monocytes (PBM) and alveolar macrophages (AM) derived 
from subjects with normal differential count of BAL cells (AM>85), increase in lymphocytes (lymphocytes> 15%), increase in 
neutrophils (neutrophils>5%), and pooled data. The values represent mean percentage of positive cells & SD 
Normal differential Increase in lymphocytes 
count (AM>85%) (lymphocytes> 15%) 
PBM AM PBM AM 
Increase in neutrophils 
(neutrophils>5%) 
PBM AM 
Pooled data 
PBM AM 
CD49b 
CD49d 
CD49e 
CD49f 
CDlla 
CDllb 
CD1 lc 
CD18 
CD51 
CD54 
l&O 253 l&O 8zt 12 llt0 4XlZ7 1**0 5zt9 
4*4 17 h 15 8& 15 32 z!z 19 6+7 20* 16 7*11 24% 18 
74+ 15 89zt9 66& 14 94 zt 9 61 h 17 87* 18 68 zt 16 91&11 
1Zt.o If1 1*2 10 f 14 l&O 4*4 1*1 6% 10 
62 rt 9 77Zt 15 65% 15 84 * 12 61 ~t27 67 f 9 64& 16 79 zk 14 
89 It 12 65 f 23 90 * 7 73Xt 15 96*4 70 + 10 91*8 7Oi 16 
36 f 22 75 * 12 42% 18 77 zk 14 35 f 13 69 zt 7 39It 18 75 zt 12 
56% 18 66& 16 68+ 16 77~t 16 63 z!z 26 64+ 13 63 i 14 70% 17 
l?cO 27+21 l&O 48* 19 l&O 35 + 8 llt0 39 * 20 
lZt0 29 z!c 14 1*1 54 zt 23 l&O 40* 15 lrtl 43 * 22 
The CD49d antigen was found on 24 * 18% of AM and 
only on 7 * 11% of PBM monocytes (P<O.OOl). A higher 
expression of this molecule by AM was detected in patients 
with a lymphocytic predominance of BAL cells than in 
those having a normal differential count of BAL cells 
(32 f 19% vs 17 & 15%, P<O.O5). 
The CD49e antigen was expressed by 91 f 11% of AM 
and by 68 & 16% of PBM (P<O.OOl). A negative correlation 
was found between CD49e expression on blood and 
alveolar mononuclear phagocytes (r= - 0.3123, P=O.O482). 
The CD49f antigen was detected on a low percentage of 
cells: on 6 * 10% of AM (range O-44), and monocytes 
(1 f l%, range O-8%) (P<O.OOl). 
MOLECULES OF /?, INTEGRIN FAMILY 
The CDlla antigen was expressed on a higher percentage 
of AM (79 & 14%) as compared to PBM (64 It 16%) 
(PCO.001). : I 
The CD1 lb antigen was found more frequently on PB?4 
(91 * 8%) than on AM (70 & 16%) (P<O*OOl). 
The CD1 lc antigen was detected on a higher percentage 
of AM (75 & 12%) as compared to PBM (39 & 18%) 
(P<O.OOl). 
The CD18 antigen was found on 70 & 17% of AM and 
63 & 19% of peripheral blood monocytes (P<O.OOl). 
Other integrins 
The CD5 1 (J3, integrin, a vitronectin receptor) was detected 
exclusively on AM (39 rfr 20%) and not on blood monocytes 
(~1%) (P<O.OOl). AM from patients with a predominance 
of lymphocytes in BAL fluid expressed this receptor more 
frequently (48 & 19%) than those with a normal BAL 
differential count (27 & 21%). 
The CD54 (ICAM-1; intercellular adhesion molecule-l) 
was expressed more frequently on AM (43 & 22%) than on 
peripheral blood monocytes (1 f 1%) (P<O.OOl). Patients 
with a lymphocytic alveolitis had a higher expression of 
CD54 (54& 23%) on AM than patients with normal 
proportions of BAL cells (29 f 14%). 
Discussion 
This study demonstrates a higher expression by AM than 
by PBM of all but one of the studied adhesion molecules. 
The various molecules of the /I1 integrin family (known as 
‘very late antigens’, VLA) mediate binding of phagocytes to 
extracellular matrix proteins by recognition of binding sites 
on collagen, laminin, and fibronectin (10). Both AM and 
monocytes predominantly expressed the CD49e antigen 
(alpha 5 chain, VLA-5), which is the receptor for the RGD 
binding site of fibronectin (11). Although this antigen can 
be upregulated on human leukocytes by stimulation, no 
important changes were found in its expression by AM in 
various disease states. 
The CD49d molecule (alpha 4 chain, VLA-4) recogniz- 
ing VCAM-1 and the determinant within the IIICS domain 
of fibronectin (12), showed a higher expression on AM in 
patients with a lymphocytic alveolitis, in agreement with 
previous preliminary data (13). The CD49b and CD49f 
antigens were both rarely expressed on mononuclear 
phagocytes, with only a weak membrane reaction. A pre- 
vious study also showed a low expression of CD49b on 
freshly isolated blood monocytes (14). 
Antigens of the & integrin family seem to be very 
common molecules on the surface of mononuclear phago- 
cytes. CD1 la (alpha chain of LFA-1) was expressed 
more frequently on AM than on blood monocytes. 
Although in vitro maturation of mononuclear phagocytes is 
associated with a decrease in CDlla expression (15), 
previous studies showed a very similar high expression of 
this molecule on human AM (3). Environmental factors 
may be responsible for the maintenance of LFA-1 on the 
AM membrane. CDllb showed a higher expression 
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alveolar macrophages 
FIG. 1. Schematic representation of the changes in the expression of adhesion molecules during the transition from blood 
monocyte to alveolar macrophage. Values represent mean differences in the expression of adhesion molecules by AM and 
PBM (% of positive AM minus ;/o of positive PBM). 
of PBM than on AM but it should be noted that this 
molecule may be rapidly mobilized from intracellular 
stores in response to stimulation (16). However, a similar 
pattern in the expression of CD1 lb by AM and PBM has 
been shown in a recent study (17). The CDllc antigen 
was expressed to a much higher extent on AM than on 
PBM as could be expected from the differentiation-related 
regulation of this molecule (18). The present study did not 
confirm the profound changes in the expression of this 
molecule seen previously in interstitial lung diseases (4) 
and in smokers (19). Similarly, the CD18 molecule (the 
common beta chain of /J2 integrins) appears to be 
rather constitutively expressed, and was more frequently 
observed on AM than on PBM. In many cases, the 
expression of CD 18 was lower than the expression of alpha 
chains which is not due to a CD18 downregulation but 
rather is associated with different sensitivity of epitopes 
to fixation. In our standardization experiments with 
different fixatives and incubation times we found CD18 
to be relatively vulnerable compared to other membrane 
antigens. 
CD51, the only studied member of the ,& integrin family, 
was detected exclusively on AM. Whether the higher 
expression of this vitronectin receptor on AM has a rela- 
tionship to increased levels of vitronectin in BAL fluid (20) 
should be clarified by further studies. Our study showed an 
enhanced expression of CD51 on AM from subjects with a 
lymphocytic BAL pattern. 
CD54 (ICAM-1, intercellular adhesion molecule-l) is a 
member of the immunoglobulin superfamily serving as a 
ligand for /& integrins (21). Previous studies showed an 
increased expression of CD54 on AM of subjects with 
active interstitial lung diseases (24). Also in this study, 
CD54 expression on AM was higher in patients with a 
lymphocytic BAL pattern. This antigen was not detectable 
on blood monocytes in contrast to the basal expression 
shown by others (2,14). One of the possible explanations is 
very effective blocking of the non-specific binding of anti- 
bodies in our assay. The high expression on AM may be 
related to the reported local production of strong CD54 
inducers, i.e. interferon-gamma (TFN-y) (22) and tumour 
necrosing factor-alpha (TNF-a) (23): as described in 
sarcoid patients. 
There are several factors to be mentioned which might 
possibly affect the expression of membrane antigens. AM of 
smokers are chronically stimulated by tobacco smoke 
which might alter AM phenotype, and there are published 
data on the effect of tobacco smoke on integrin expression 
(19). In contrast, we have not observed such a correlation in 
our previous studies (3,8,13) using the current method of 
immunostaining. 
In conclusion, we demonstrated that the phenotypic 
profile of adhesion molecules on mononuclear phagocytes 
shows a marked difference between AM and PBM. We are 
aware that the expression of adhesion molecules might not 
necessarily reflect their binding capacity (24). On the other 
hand, changes in the AM phenotype induced by micro- 
environmental stimuli may provide new tools for assessing 
the activity of inflammatory lung processes. Since adhesion 
molecules were found to be important targets of anti- 
inflammatory immunotherapy in animal models of lung 
inflammation (25), detailed information regarding the dis- 
tribution of integrins in the human body is necessary. 
Differences in the constitutive expression of several 
integrins between AM and PBM may also be partly 
responsible for some functional differences. 
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